RKS-15108-39217
4 vaccinations
1 coded response
40 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 601 / IL
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
U2D-86299-03357
Child or adolescent in my care · Female · 2022-06-26
Timeline
-
2021-01-15
Registered in v-safe
-
2021-01-15
Dose 1 — Pfizer-BioNTech
- 2021-01-15
-
2021-01-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-18
- 2021-01-21
- 2021-01-22
- 2021-01-29
-
2021-02-05
Dose 2 — Pfizer-BioNTech
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-05-07
- 2021-08-06
-
2021-10-08
Dose 3 — Pfizer-BioNTech
- 2021-10-12
- 2021-10-13
- 2021-10-14
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2022-01-07
- 2022-04-08
-
2022-10-08
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-12-11
Dose 4 — Moderna
-
2022-12-12
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-12-13
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2022-12-14
- 2022-12-15
- 2022-12-16
- 2022-12-17
- 2022-12-18
- 2022-12-25
- 2023-01-01
- 2023-01-08
- 2023-01-15
- 2023-01-22
- 2023-03-12
- 2023-06-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Pfizer-BioNTech | |
| 2 | 2021-02-05 | Pfizer-BioNTech | |
| 3 | 2021-10-08 | Pfizer-BioNTech | No |
| 4 | 2022-12-11 | Moderna | No |
Free text
Release 12 — 12 months, dose 3
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release